Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bromodomain-containing protein 3 [326-398] | ||
Ligand | BDBM179627 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | FP Competitive Binding Assay (No.350) | ||
Temperature | 298.15±n/a K | ||
Ki | 2.20±n/a nM | ||
Comments | extracted | ||
Citation | Wang, S; Ran, X; Zhao, Y; Yang, C; Liu, L; Bai, L; McEachern, D; Stuckey, J; Meagher, JL; Sun, D; Li, X; Zhou, B; Karatas, H; Luo, R; Chinnaiyan, A; Asangani, IA BET bromodomain inhibitors and therapeutic methods using the same US Patent US9675697 Publication Date 6/13/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Bromodomain-containing protein 3 [326-398] | |||
Name: | Bromodomain-containing protein 3 [326-398] | ||
Synonyms: | BRD3 | BRD3_HUMAN | Bromodomain-containing protein 3 (BRD3)(BD2) | Bromodomain-containing protein 3 Bromo 2 domain(BRD3 BD2) | KIAA0043 | RING3L | ||
Type: | n/a | ||
Mol. Mass.: | 8553.07 | ||
Organism: | Homo sapiens (Human) | ||
Description: | BD2 (326-398 aa) of Q15059 | ||
Residue: | 73 | ||
Sequence: |
| ||
BDBM179627 | |||
n/a | |||
Name | BDBM179627 | ||
Synonyms: | US9675697, Cpd. No. 213 | ||
Type | Small organic molecule | ||
Emp. Form. | C33H39N7O4 | ||
Mol. Mass. | 597.7073 | ||
SMILES | COc1cc2c(cc1-c1c(C)noc1C)[nH]c1nc(C)nc(-c3cc([nH]c3C(C)C)C(=O)NC3CCN(CC3)C3COC3)c21 |(-1.5,3.22,;-2.13,1.81,;-1.36,.48,;.18,.48,;.95,-.85,;.18,-2.19,;-1.36,-2.19,;-2.13,-.85,;-3.67,-.85,;-4.57,-2.1,;-4.18,-3.59,;-6.04,-1.62,;-6.04,-.08,;-4.57,.39,;-4.18,1.88,;1.21,-3.33,;2.62,-2.71,;4.03,-3.33,;5.27,-2.43,;6.68,-3.05,;5.11,-.9,;3.7,-.27,;3.31,1.22,;2.06,2.12,;2.54,3.59,;4.08,3.59,;4.55,2.12,;6.04,1.72,;6.44,.24,;7.13,2.81,;1.63,4.83,;.1,4.67,;2.26,6.24,;1.35,7.49,;1.98,8.89,;1.07,10.14,;-.46,9.98,;-1.09,8.57,;-.18,7.33,;-1.36,11.22,;-2.87,11.54,;-2.63,13.15,;-1.13,12.65,;2.46,-1.17,)| | ||
Structure |